LAUREN MACCHIO: Open Payments
NPI 1235707514 · WARWICK, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,931 in 70 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $360 · 2025 $1,931
Food & beverage: $1,931
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $661 |
| GENZYME CORPORATION | 17 | $558 |
| Regeneron Healthcare Solutions, Inc. | 11 | $220 |
| GlaxoSmithKline, LLC. | 9 | $192 |
| PFIZER INC. | 3 | $69 |
| Optinose US, Inc. | 2 | $52 |
| Stryker Corporation | 1 | $49 |
| ABBVIE INC. | 2 | $45 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $38 |
| Paratek Pharmaceuticals, Inc. | 1 | $26 |
Products named: DUPIXENT, AIRSUPRA, NUCALA, TEZSPIRE, FASENRA, Xhance, NURTEC ODT, BREZTRI.
Industry payments across RI — which companies pay providers there.
